Haemaprot 1.4mg Infusion
Marketer
Troikaa Pharmaceuticals Ltd
Salt Composition
Aprotinin (1.4mg)
Overview Haemaprot 1.4mg Infusion
Administered by a healthcare professional only, Haemaprot 1.4mg Infusion manages excessive bleeding. Its use encompasses post-surgical hemorrhage reduction, and conditions like menorrhagia, abnormal uterine bleeding, and epistaxis. Self-administration is strictly prohibited. Prior to use, disclose any allergies to this medication. Injection site reactions (pain, swelling, redness) are possible; report any discomfort to your physician. Furthermore, inform your doctor of any history of cardiac surgery or liver impairment.
Primary Ingredients of Haemaprot 1.4mg Infusion
There is no text provided to rephrase. Please provide the text you would like me to rewrite.
Uses of Haemaprot 1.4mg Infusion
Hemorrhage
Major Benefits of Haemaprot 1.4mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Haemaprot 1.4mg Infusion:
- Injection site reactions (pain, swelling, redness)
How to use Haemaprot 1.4mg Infusion:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Haemaprot 1.4mg Infusion works:
Haemaprot 1.4mg infusion stabilizes blood clots, thereby halting hemorrhage.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Haemaprot 1.4mg Infusion may pose unknown risks. Seek medical advice before combining them.
PregnancySAFE IF PRESCRIBED
The intravenous administration of Haemaprot at a 1.4mg dose is typically deemed safe for pregnant individuals. Preclinical trials in animals revealed minimal or no harmful consequences to the fetus; nevertheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
Breastfeeding mothers can likely use Haemapot 1.4mg Infusion without significant risk to their infants. Available human data indicates minimal infant exposure to the drug.
DrivingNOT RELEVANT
Inapplicable, since Haemaprot 1.4mg Infusion is administered exclusively in the inpatient setting.
KidneySAFE IF PRESCRIBED
The administration of Haemaprot 1.4mg Infusion to patients with renal impairment appears to present a low risk. Preliminary evidence indicates dose modification of Haemaprot 1.4mg Infusion may be unnecessary for this population. Physician consultation is advised.
LiverCONSULT YOUR DOCTOR
Data regarding the administration of 1.4mg Haemaprot infusions to individuals with hepatic impairment is scarce. Physician consultation is advised.
What if you forget to take Haemaprot 1.4mg Infusion :
Omit any missed dose of Haemaprot 1.4mg Infusion and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Haemaprot 1.4mg Infusion
| Label | Value |
|---|---|
| Chemical Category | Amino Acid and Peptide Analogs |
| Developing Habits | No. |
| Treatment Category | KINSHIP |
| Behavioral Class | Clot stabilizer |
3,018 People bought this recently